Pfizer Inc and Pharmacia Corporation jointly announced today that they have signed a definitive agreement providing for Pfizer to acquire Pharmacia in a stock-for-stock transaction valued at $60 billion, expanding the company's core strengths in pharmaceuticals and health care. Pharmacia also announced that its Board of Directors intends to proceed with its previously announced spin-off of its remaining 84% ownership of Monsanto to its current shareholders. "This is an extraordinary ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Pfizer To Acquire Pharmacia, you'll get exclusive access to a large archive of premium content.

Already registered? here.